IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
Good morning, everyone. I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Thanks so much for joining us. Our next featured company is IGM Biosciences represented by their CEO, Fred Schwarzer. Fred, thanks so much for joining us in person today.
Well, thanks for having, having us. It's a great pleasure to be able to be here in person again.
Questions & Answers
It's great to see you. So lot, lots going on. Lots to talk about. Maybe let's just start with the latest news. You've recently announced a broad collaboration with Sanofi. Can you talk about what drove you to pursue a transaction like this? And why Sanofi and how can some of your areas of interest and expertise potentially synergize with one another?
Yeah, this -- the structure of the transaction
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
